Juan Manuel Alonso-Domínguez (Juan M Alonso-Dominguez, Juan-Manuel Alonso-Dominguez, Juan Manuel Alonso-Dominguez, Juan-Manuel Alonso-Domínguez, Juan M Alonso-Domínguez)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 35

Top Venues

Clinical and translational science

Cancers

Medicina (Kaunas, Lithuania)

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Rupa Narayan, Ana Alfonso Piérola, William B Donnellan, Antonieta Molero Yordi, Maher Abdul-Hay, Uwe Platzbecker, Marion Subklewe, Tapan Mahendra Kadia, Juan Manuel Alonso-Domínguez, James McCloskey, Kathryn Bradford, Martin Curtis, Nikki Daskalakis, Christina Guttke, Karim Safer, Brett Hiebert, Joseph Murphy, Xiang Li, Ken Duchin, Daniel Esteban
First-in-human study of JNJ-67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome. Clinical and translational science 17 (3) (2024)
Tamara Castaño-Bonilla, Raquel Mata, Daniel Lainez-González, Raquel Gonzalo, Susana Castañón, Francisco Javier Diaz De La Pinta, Carlos Blas López, Jose Luis Lopez-Lorenzo, Juan Manuel Alonso-Domínguez
Spontaneous Remission of Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report. Medicina (Kaunas, Lithuania) 60 (5) (2024)
Tamara Castaño-Bonilla, Raquel Mata, Daniel Lainez-González, Raquel Gonzalo, Susana Castañón, Francisco Javier Diaz De La Pinta, Carlos Blas López, Jose Luis Lopez-Lorenzo, Juan Manuel Alonso-Domínguez
Spontaneous Remission of Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report. Medicina (Kaunas, Lithuania) 60 (5) (2024)
Rupa Narayan, Ana Alfonso Piérola, William B Donnellan, Antonieta Molero Yordi, Maher Abdul-Hay, Uwe Platzbecker, Marion Subklewe, Tapan Mahendra Kadia, Juan Manuel Alonso-Domínguez, James McCloskey, Kathryn Bradford, Martin Curtis, Nikki Daskalakis, Christina Guttke, Karim Safer, Brett Hiebert, Joseph Murphy, Xiang Li, Ken Duchin, Daniel Esteban
First-in-human study of JNJ-67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome. Clinical and translational science 17 (3) (2024)
Rupa Narayan, Ana Alfonso Piérola, William B Donnellan, Antonieta Molero Yordi, Maher Abdul-Hay, Uwe Platzbecker, Marion Subklewe, Tapan Mahendra Kadia, Juan Manuel Alonso-Domínguez, James McCloskey, Kathryn Bradford, Martin Curtis, Nikki Daskalakis, Christina Guttke, Karim Safer, Brett Hiebert, Joseph Murphy, Xiang Li, Ken Duchin, Daniel Esteban
First-in-human study of JNJ-67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome. Clinical and translational science 17 (3) (2024)
Rupa Narayan, Ana Alfonso Piérola, William B Donnellan, Antonieta Molero Yordi, Maher Abdul-Hay, Uwe Platzbecker, Marion Subklewe, Tapan Mahendra Kadia, Juan Manuel Alonso-Domínguez, James McCloskey, Kathryn Bradford, Martin Curtis, Nikki Daskalakis, Christina Guttke, Karim Safer, Brett Hiebert, Joseph Murphy, Xiang Li, Ken Duchin, Daniel Esteban
First-in-human study of JNJ-67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome. Clinical and translational science 17 (3) (2024)
Michael Boyiadzis, Pinkal Desai, Nikki Daskalakis, William Donnellan, Lucille Ferrante, Jenna D Goldberg, Michael R Grunwald, Christina Guttke, Xiang Li, Jose Antonio Perez-Simon, Olga Salamero, Trevor Tucker, Xiaoying Xu, Jay Yang, Naveen Pemmaraju, Juan Manuel Alonso-Domínguez
First-in-human study of JNJ-63709178, a CD123/CD3 targeting antibody, in relapsed/refractory acute myeloid leukemia. Clinical and translational science 16 (3) (2023)
Claudia Sargas, Rosa María Ayala, María J Larráyoz, María C Chillón, Eduardo Rodríguez Arbolí, Cristina Bilbao, Esther Prados de la Torre, David Martínez-Cuadrón, Rebeca Rodriguez-Veiga, Blanca Boluda, Cristina Gil, Teresa Bernal, Juan-Miguel Bergua, Lorenzo Algarra, María Del Mar Tormo Díaz, Pilar Martínez-Sánchez, Elena Soria, Josefina Serrano, Juan Manuel Alonso-Domínguez, Raimundo García, María Luz Amigo, Pilar Herrera-Puente, María J Sayas, Esperanza Lavilla-Rubira, Joaquín Martínez-López, María-José Calasanz, Miriam Santero, José Antonio Pérez-Simón, María T Gómez Casares, Joaquín Sánchez-García, Eva Barragán, Pau Montesinos, null null
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group. Blood cancer journal 13 (1) (2023)
Claudia Sargas, Rosa María Ayala, María José Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao-Sieyro, Esther Prados de la Torre, David Martínez-Cuadrón, Rebeca Rodríguez-Veiga, Blanca Boluda, Cristina Gil, Teresa Bernal Del Castillo, Juan Miguel Bergua, Lorenzo Algarra, María Del Mar Tormo Díaz, Pilar Martínez-Sánchez, Elena Soria, Josefina Serrano, Juan Manuel Alonso-Domínguez, Raimundo García-Boyero, María Luz Amigo, Pilar Herrera-Puente, María José Sayas, Esperanza Lavilla-Rubira, Joaquin Martinez Lopez, María-José Calasanz, Miriam Santero, José Antonio Pérez-Simón, María Teresa Gómez-Casares, Joaquín Sánchez-García, Eva Barragán, Pau Montesinos, null On Behalf Of Pethema Group
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry. Cancers 15 (2) (2023)
Claudia Sargas, Rosa María Ayala, María J Larráyoz, María C Chillón, Eduardo Rodríguez Arbolí, Cristina Bilbao, Esther Prados de la Torre, David Martínez-Cuadrón, Rebeca Rodriguez-Veiga, Blanca Boluda, Cristina Gil, Teresa Bernal, Juan-Miguel Bergua, Lorenzo Algarra, María Del Mar Tormo Díaz, Pilar Martínez-Sánchez, Elena Soria, Josefina Serrano, Juan Manuel Alonso-Domínguez, Raimundo García, María Luz Amigo, Pilar Herrera-Puente, María J Sayas, Esperanza Lavilla-Rubira, Joaquín Martínez-López, María-José Calasanz, Miriam Santero, José Antonio Pérez-Simón, María T Gómez Casares, Joaquín Sánchez-García, Eva Barragán, Pau Montesinos, null null
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group. Blood cancer journal 13 (1) (2023)
Claudia Sargas, Rosa María Ayala, María José Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao-Sieyro, Esther Prados de la Torre, David Martínez-Cuadrón, Rebeca Rodríguez-Veiga, Blanca Boluda, Cristina Gil, Teresa Bernal Del Castillo, Juan Miguel Bergua, Lorenzo Algarra, María Del Mar Tormo Díaz, Pilar Martínez-Sánchez, Elena Soria, Josefina Serrano, Juan Manuel Alonso-Domínguez, Raimundo García-Boyero, María Luz Amigo, Pilar Herrera-Puente, María José Sayas, Esperanza Lavilla-Rubira, Joaquin Martinez Lopez, María-José Calasanz, Miriam Santero, José Antonio Pérez-Simón, María Teresa Gómez-Casares, Joaquín Sánchez-García, Eva Barragán, Pau Montesinos, null On Behalf Of Pethema Group
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry. Cancers 15 (2) (2023)
Daniel Lainez-González, Ana Belén Alonso-Aguado, Juan Manuel Alonso-Domínguez
Understanding the Wnt Signaling Pathway in Acute Myeloid Leukemia Stem Cells: A Feasible Key against Relapses. Biology 12 (5) (2023)
Michael Boyiadzis, Pinkal Desai, Nikki Daskalakis, William Donnellan, Lucille Ferrante, Jenna D Goldberg, Michael R Grunwald, Christina Guttke, Xiang Li, Jose Antonio Perez-Simon, Olga Salamero, Trevor Tucker, Xiaoying Xu, Jay Yang, Naveen Pemmaraju, Juan Manuel Alonso-Domínguez
First-in-human study of JNJ-63709178, a CD123/CD3 targeting antibody, in relapsed/refractory acute myeloid leukemia. Clinical and translational science 16 (3) (2023)
Rosa Ayala, Gonzalo Carreño-Tarragona, Eva Barragán, Blanca Boluda, María José Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao-Sieyro, Joaquín Sánchez-García, Teresa Bernal, David Martínez-Cuadrón, Cristina Gil, Josefina Serrano, Carlos Rodriguez-Medina, Juan Bergua, José Antonio Pérez-Simón, María Calbacho, Juan Manuel Alonso-Domínguez, Jorge Labrador-Gomez, Mar Tormo, Maria Luz Amigo, Pilar Herrera-Puente, Inmaculada Rapado, Claudia Sargas, Iria Vazquez, María-José Calasanz, Teresa Gomez-Casares, Miriam Santero, Miguel Angel Sanz, Joaquin Martinez Lopez, Pau Montesinos
Impact of FLT3-ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study. Cancers 14 (23) (2022)
Inés Martínez-Alfonzo, Daniel Lainez-González, Laura Solán, Aida Franganillo-Suarez, José I Cornejo, Amanda Garcia-Lopez, Sara Martín-Herrero, Tamara Castaño-Bonilla, Rocío Salgado-Sánchez, Teresa Arquero-Portero, María J Cortti-Ferrari, Pilar Llamas-Sillero, Juan Manuel Alonso-Domínguez
Flow Cytometry and Molecular Techniques Could Complement Morphological Detection of Leukemic Infiltration in Ascitic Fluids: A Case Report. Medicina (Kaunas, Lithuania) 58 (2) (2022)
Rosa Ayala, Gonzalo Carreño-Tarragona, Eva Barragán, Blanca Boluda, María José Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao-Sieyro, Joaquín Sánchez-García, Teresa Bernal, David Martínez-Cuadrón, Cristina Gil, Josefina Serrano, Carlos Rodriguez-Medina, Juan Bergua, José Antonio Pérez-Simón, María Calbacho, Juan Manuel Alonso-Domínguez, Jorge Labrador-Gomez, Mar Tormo, Maria Luz Amigo, Pilar Herrera-Puente, Inmaculada Rapado, Claudia Sargas, Iria Vazquez, María-José Calasanz, Teresa Gomez-Casares, Miriam Santero, Miguel Angel Sanz, Joaquin Martinez Lopez, Pau Montesinos
Impact of FLT3-ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study. Cancers 14 (23) (2022)
Michael Boyiadzis, Pinkal Desai, Nikki Daskalakis, William Donnellan, Lucille Ferrante, Jenna D Goldberg, Michael R Grunwald, Christina Guttke, Xiang Li, Jose Antonio Perez-Simon, Olga Salamero, Trevor Tucker, Xiaoying Xu, Jay Yang, Naveen Pemmaraju, Juan Manuel Alonso-Domínguez
First-in-Human Study of JNJ-63709178, a CD123/CD3 Targeting Antibody, in Relapsed/Refractory Acute Myeloid Leukemia. Clinical and translational science (2022)
Yolanda Martínez-Díez, Aida Franganillo-Suárez, Rocío Salgado-Sánchez, Mireia Atance-Pasarisas, Carlos Blas López, María José Cotti-Ferrari, Tamara Castaño-Bonilla, Daniel Lainez-González, Socorro María Rodríguez-Pinilla, Pilar Llamas-Sillero, Juan Manuel Alonso-Domínguez
Spontaneous Remission of Acute Myeloid Leukemia: A Case Report. Medicina (Kaunas, Lithuania) 58 (7) (2022)
Rosa Ayala, Gonzalo Carreño-Tarragona, Eva Barragán, Blanca Boluda, María José Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao-Sieyro, Joaquín Sánchez-García, Teresa Bernal, David Martínez-Cuadrón, Cristina Gil, Josefina Serrano, Carlos Rodriguez-Medina, Juan Bergua, José Antonio Pérez-Simón, María Calbacho, Juan Manuel Alonso-Domínguez, Jorge Labrador-Gomez, Mar Tormo, Maria Luz Amigo, Pilar Herrera-Puente, Inmaculada Rapado, Claudia Sargas, Iria Vazquez, María-José Calasanz, Teresa Gomez-Casares, Miriam Santero, Miguel Angel Sanz, Joaquin Martinez Lopez, Pau Montesinos
Impact of FLT3-ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study. Cancers 14 (23) (2022)
Fernando Sánchez-Vizcaíno, Carmen Tamayo, Fernando Ramos, Daniel Lainez-González, Juana Serrano-López, Raquel Barba, Maria Dolores Martin, Pilar Llamas, Juan Manuel Alonso-Domínguez
Identification of seasonal variation in the diagnosis of acute myeloid leukaemia: a population-based study. British journal of haematology 198 (3) (2022)
Daniel Lainez-González, Juana Serrano-López, Juan Manuel Alonso-Domínguez
Understanding the Notch Signaling Pathway in Acute Myeloid Leukemia Stem Cells: From Hematopoiesis to Neoplasia. Cancers 14 (6) (2022)
Michael Boyiadzis, Pinkal Desai, Nikki Daskalakis, William Donnellan, Lucille Ferrante, Jenna D Goldberg, Michael R Grunwald, Christina Guttke, Xiang Li, Jose Antonio Perez-Simon, Olga Salamero, Trevor Tucker, Xiaoying Xu, Jay Yang, Naveen Pemmaraju, Juan Manuel Alonso-Domínguez
First-in-human study of JNJ-63709178, a CD123/CD3 targeting antibody, in relapsed/refractory acute myeloid leukemia. Clinical and translational science (2022)
David Martínez-Cuadrón, Josefina Serrano, José Mário Mariz, Cristina Gil, Mar Tormo, Pilar Martínez-Sánchez, Eduardo Rodríguez-Arbolí, Raimundo García-Boyero, Carlos Rodríguez-Medina, Carmen Martínez-Chamorro, Marta Polo, Juan Bergua, Eliana Aguiar, María L Amigo, Pilar Herrera, Juan Manuel Alonso-Domínguez, Teresa Bernal Del Castillo, Ana Espadana, María J Sayas, Lorenzo Algarra, Maria Vidriales Vicente, Graça Vasconcelos, Susana Vives, Manuel Mateo Pérez Encinas, Aurelio López, Víctor Noriega, María García-Fortes, María C Chillón, Juan I Rodríguez-Gutiérrez, María-José Calasanz, Jorge Labrador-Gomez, Juan A López, Blanca Boluda, Rebeca Rodríguez-Veiga, Joaquin Martinez Lopez, Eva Barragán, Miguel Angel Sanz, Pau Montesinos, null On Behalf Of The Pethema Group
Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory FLT3 -ITD Mutation-Positive Acute Myeloid Leukemia. Cancers 14 (11) (2022)
Tamara Castaño-Bonilla, Eva Barragán, Claudia Sargas, Alejandro Sanz, Lorenzo Algarra, Pilar Herrera-Puente, Raimundo García-Boyero, Manuel Barrios, David Martínez-Cuadrón, Rebeca Rodriguez-Veiga, Blanca Boluda, Cristina Gil, Josefina Serrano-López, Joaquin Martinez Lopez, María José Sayas-Lloris, María Teresa Olave, Rosalía Riaza-Grau, Teresa Bernal-Del Castillo, María José Larráyoz, Raquel Amigo, Antonio Jiménez-Velasco, Joaquín Sánchez, Rosa María Ayala, Carlos Blas López, Daniel Lainez-González, Juana Serrano-López, Miguel Angel Sanz, Juan Manuel Alonso-Domínguez, Pau Montesinos
No Evidence that CD33 rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA Group. Disease markers 2022 (2022)
Rosa Ayala, Gonzalo Carreño-Tarragona, Eva Barragán, Blanca Boluda, María José Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao-Sieyro, Joaquín Sánchez-García, Teresa Bernal, David Martínez-Cuadrón, Cristina Gil, Josefina Serrano, Carlos Rodriguez-Medina, Juan Bergua, José Antonio Pérez-Simón, María Calbacho, Juan Manuel Alonso-Domínguez, Jorge Labrador-Gomez, Mar Tormo, Maria Luz Amigo, Pilar Herrera-Puente, Inmaculada Rapado, Claudia Sargas, Iria Vazquez, María-José Calasanz, Teresa Gomez-Casares, Miriam Santero, Miguel Angel Sanz, Joaquin Martinez Lopez, Pau Montesinos
Impact of FLT3-ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study. Cancers 14 (23) (2022)
Diego Velasco-Rodríguez, Juan Manuel Alonso-Domínguez, Rosa Vidal Laso, Daniel Lainez-González, Aránzazu García-Raso, Sara Martín-Herrero, Antonio Herrero, Inés Martínez Alfonzo, Juana Serrano-López, Elena Jiménez-Barral, Sara Nistal, Manuel Pérez Márquez, Elham Askari, Jorge Castillo Álvarez, Antonio Núñez, Ángel Jiménez Rodríguez, Sarah Béatrice Heili, César Pérez-Calvo, Miguel Górgolas, Raquel Barba, Pilar Llamas-Sillero
Development and validation of a predictive model of in-hospital mortality in COVID-19 patients. PloS one 16 (3) (2021)
Daniel Lainez-González, Juana Serrano-López, Juan Manuel Alonso-Domínguez
Understanding the Hedgehog Signaling Pathway in Acute Myeloid Leukemia Stem Cells: A Necessary Step toward a Cure. Biology 10 (4) (2021)
Tamara Castaño-Bonilla, Juan Manuel Alonso-Domínguez, Eva Barragán, Rebeca Rodríguez-Veiga, Claudia Sargas, Cristina Gil, Carmen Chillón, María B Vidriales, Raimundo García, Joaquín Martínez-López, Rosa Ayala, María J Larrayoz, Eduardo Anguita, Rebeca Cuello, Alberto Cantalapiedra, Estrella Carrillo, Elena Soria-Saldise, Jorge Labrador, Isabel Recio, Lorenzo Algarra, Carlos Rodríguez-Medina, Cristina Bilbao-Syeiro, Juan A López-López, Josefina Serrano, Erik De Cabo, María J Sayas, María T Olave, Joaquín Sánchez-García, Mamen Mateos, Carlos Blas, Jose L López-Lorenzo, Daniel Lainez-Gonzalez, Juana Serrano, David Martínez-Cuadrón, Miguel A Sanz, Pau Montesinos
Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens. Scientific reports 11 (1) (2021)
Juan José Lahuerta, Maria Vidriales Vicente, Amparo Sempere, Fabián Tarín, Enrique Colado, Celina Benavente, María-Teresa Cedena, Joaquín Sánchez, Teresa Caballero-Velazquez, Lourdes Cordon, Juan-José Garcés, Catia Simoes, David Martínez-Cuadrón, Teresa Bernal Del Castillo, Carmen Botella, Sofia Grille, Josefina Serrano, Carlos Rodríguez-Medina, Lorenzo Algarra, Juan Manuel Alonso-Domínguez, María-Luz Amigo, Manuel Barrios, Raimundo García-Boyero, Mercedes Colorado, Jaime Pérez-Oteyza, Manuel Mateo Pérez Encinas, Lisette Costilla-Barriga, María-José Sayas, Olga Pérez, Marcos González-Díaz, José A Pérez-Simón, Joaquin Martinez Lopez, Claudia Sossa, Alberto Orfao, Jesús F San Miguel, Miguel Angel Sanz, Pau Montesinos, null null
Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia. Leukemia 35 (8) (2021)
Alicia Arenas Cortés, Susana Olmedillas, Juana Serrano-López, Daniel Lainez-González, Tamara Castaño, Rodrigo Iñiguez, José Luis Lopez-Lorenzo, Amanda García, Mireia Atance, Rocío Nieves Salgado Sánchez, Carlos Blas Lopez, Mariano García Arranz, Pilar Llamas Sillero, Juan Manuel Alonso-Domínguez
Comparison of Droplet Digital PCR versus qPCR Measurements on the International Scale for the Molecular Monitoring of Chronic Myeloid Leukemia Patients. Molecular diagnosis & therapy 24 (5) (2021)
María Angeles Pérez-Sáenz, Socorro Maria Rodriguez-Pinilla, Rocío N Salgado, Nerea Carvajal, Cristina Serrano, Carlos Soto, Juana Serrano, Mireia Atance, José Luis López-Lorenzo, Luis Requena, Federico Rojo, Miguel Angel Piris, Pilar Llamas, Juan Manuel Alonso-Domínguez
Three monocytic neoplasms in a single patient. Leukemia & lymphoma 61 (10) (2020)
Manuel Méndez, María Isabel Moreno-Carralero, Valeria L Peri, Rafael Camacho-Galán, José M Bosch-Benítez, Jorge Huerta, Jorge Sánchez-Calero-Guilarte, María Belén Moreno-Risco, Juan Manuel Alonso-Domínguez, María-José Morán-Jiménez
Congenital dyserythropoietic anemia types Ib, II, and III: novel variants in the CDIN1 gene and functional study of a novel variant in the KIF23 gene. Annals of hematology 100 (2) (2020)
David Martínez-Cuadrón, Josefina Serrano, Cristina Gil, Mar Tormo, Pilar Martínez-Sánchez, José A Pérez-Simón, Raimundo García-Boyero, Carlos Rodríguez-Medina, María López-Pavía, Celina Benavente, Juan-Miguel Bergua, Esperanza Lavilla-Rubira, María-Luz Amigo, Pilar Herrera, Juan Manuel Alonso-Domínguez, Teresa Bernal Del Castillo, Mercedes Colorado, María J Sayas, Lorenzo Algarra, Maria Vidriales Vicente, Gabriela Rodríguez-Macías, Susana Vives, Manuel Mateo Pérez Encinas, Aurelio López, Víctor Noriega, María García-Fortes, Fernando Ramos, Juan I Rodríguez-Gutiérrez, Lisette Costilla-Barriga, Jorge Labrador, Blanca Boluda, Rebeca Rodriguez-Veiga, Joaquin Martinez Lopez, Miguel Angel Sanz, Pau Montesinos
Evolving treatment patterns and outcomes in older patients (≥60 years) with AML: changing everything to change nothing? Leukemia 35 (6) (2020)
Alberto Álvarez-Larrán, Anna Angona, Marcio Andrade-Campos, M Soledad Noya, M Teresa Gómez-Casares, Beatriz Cuevas, Gonzalo Caballero, Carmen García-Hernández, Valentín García-Gutiérrez, Alicia Palomino, Francisca Ferrer-Marín, M Isabel Mata-Vázquez, Ana Moretó, Elena Magro, Ilda Murillo, Juan Manuel Alonso-Domínguez, José María Guerra, Lucía Guerrero, José María Raya, Manuel Pérez-Encinas, Gonzalo Carreño-Tarragona, Laura Fox, Irene Pastor-Galán, Beatriz Bellosillo, Juan Carlos Carlos Hernández-Boluda, null null
Cytoreductive treatment in patients with CALR-mutated essential thrombocythaemia: a study comparing indications and efficacy among genotypes from the Spanish Registry of Essential Thrombocythaemia. British journal of haematology 192 (6) (2020)
Juan Manuel Alonso-Domínguez, Luis Felipe Casado, Eduardo Anguita, Maria Teresa Gomez-Casares, Ismael Buño, Francisca Ferrer-Marín, Alicia Arenas, Rafael Del Orbe, Rosa Ayala, Pilar Llamas, Rocio N Salgado, Santiago Osorio, Pedro Sanchez-Godoy, Carmen Burgaleta, Ignacio Mahíllo-Fernández, Valentin Garcia-Gutierrez, Juan Luis Steegmann, Joaquín Martinez-Lopez
PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase. PloS one 12 (7) (2017)

Juan Manuel Alonso-Domínguez.css-eqlu8i{font-size:small;padding-left:4px;} (Juan M Alonso-Dominguez, Juan-Manuel Alonso-Dominguez, Juan Manuel Alonso-Dominguez, Juan-Manuel Alonso-Domínguez, Juan M Alonso-Domínguez)

Publication Activity (10 Years)

Top Topics

Top Venues

Juan Manuel Alonso-Domínguez (Juan M Alonso-Dominguez, Juan-Manuel Alonso-Dominguez, Juan Manuel Alonso-Dominguez, Juan-Manuel Alonso-Domínguez, Juan M Alonso-Domínguez)